Modulation of stimulation-evoked release of newly formed acetylcholine from mouse hemidiaphragm preparation. 1987

G T Somogyi, and E S Vizi, and I A Chaudhry, and H Nagashima, and D Duncalf, and F F Foldes, and P L Goldiner

A radioisotope method has been developed for measuring the stimulation-evoked release of acetylcholine without the use of cholinesterase inhibitors from the mouse hemidiaphragm preparation which had been loaded with 3H-choline. Evidence has been obtained that 3H-choline was taken up by and released from both innervated and non-innervated mouse hemidiaphragm preparations. However, it was released in the form of 3H-acetylcholine in response to electrical field stimulation only from the innervated preparations. Long lasting (51 min) S1 stimulation of the preparations exhausted the radioactive acetylcholine stores to the extent that S2 did not evoke any release of 3H. These data suggest that when the labelled acetylcholine stores become exhausted, the labelled choline, still present in the tissue, cannot be released by electrical stimulation. Tetrodotoxin (1 mumol/l) administration and Ca withdrawal inhibited, 20-100 mumol/l 4-aminopyridine enhanced the release of 3H-acetylcholine in response to electrical stimulation. Activation of the presynaptic muscarinic receptors by the agonist oxotremorine (50 mumol/l) decreased the liberation of 3H-acetylcholine. The muscarinic antagonist atropine (1 mumol/l) abolished the inhibitory effect of oxotremorine and by itself increased the evoked release of the newly formed 3H-acetylcholine. Adenosine (50 mumol/l) reduced the evoked release of radioactivity. Theophylline (30 mumol/l) prevented the inhibitory effect of adenosine and itself enhanced the release. Xylazine (1 mumol/l), an alpha 2-adrenoceptor agonist did not affect the release. It is concluded that the stimulation-evoked release of 3H-acetylcholine from the mouse phrenic nerve hemidiaphragm preparation preloaded with 3H-choline is derived from the motor nerves. The release of acetylcholine is modulated by activation of presynaptic muscarinic and adenosine receptors.

UI MeSH Term Description Entries
D008297 Male Males
D009469 Neuromuscular Junction The synapse between a neuron and a muscle. Myoneural Junction,Nerve-Muscle Preparation,Junction, Myoneural,Junction, Neuromuscular,Junctions, Myoneural,Junctions, Neuromuscular,Myoneural Junctions,Nerve Muscle Preparation,Nerve-Muscle Preparations,Neuromuscular Junctions,Preparation, Nerve-Muscle,Preparations, Nerve-Muscle
D010095 Oxotremorine A non-hydrolyzed muscarinic agonist used as a research tool. Oxytremorine
D002118 Calcium A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Coagulation Factor IV,Factor IV,Blood Coagulation Factor IV,Calcium-40,Calcium 40,Factor IV, Coagulation
D003964 Diaphragm The musculofibrous partition that separates the THORACIC CAVITY from the ABDOMINAL CAVITY. Contraction of the diaphragm increases the volume of the thoracic cavity aiding INHALATION. Respiratory Diaphragm,Diaphragm, Respiratory,Diaphragms,Diaphragms, Respiratory,Respiratory Diaphragms
D004558 Electric Stimulation Use of electric potential or currents to elicit biological responses. Stimulation, Electric,Electrical Stimulation,Electric Stimulations,Electrical Stimulations,Stimulation, Electrical,Stimulations, Electric,Stimulations, Electrical
D000109 Acetylcholine A neurotransmitter found at neuromuscular junctions, autonomic ganglia, parasympathetic effector junctions, a subset of sympathetic effector junctions, and at many sites in the central nervous system. 2-(Acetyloxy)-N,N,N-trimethylethanaminium,Acetilcolina Cusi,Acetylcholine Bromide,Acetylcholine Chloride,Acetylcholine Fluoride,Acetylcholine Hydroxide,Acetylcholine Iodide,Acetylcholine L-Tartrate,Acetylcholine Perchlorate,Acetylcholine Picrate,Acetylcholine Picrate (1:1),Acetylcholine Sulfate (1:1),Bromoacetylcholine,Chloroacetylcholine,Miochol,Acetylcholine L Tartrate,Bromide, Acetylcholine,Cusi, Acetilcolina,Fluoride, Acetylcholine,Hydroxide, Acetylcholine,Iodide, Acetylcholine,L-Tartrate, Acetylcholine,Perchlorate, Acetylcholine
D000241 Adenosine A nucleoside that is composed of ADENINE and D-RIBOSE. Adenosine or adenosine derivatives play many important biological roles in addition to being components of DNA and RNA. Adenosine itself is a neurotransmitter. Adenocard,Adenoscan
D000631 Aminopyridines Pyridines substituted in any position with an amino group. May be hydrogenated but must retain at least one double bond. Aminopyridine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

G T Somogyi, and E S Vizi, and I A Chaudhry, and H Nagashima, and D Duncalf, and F F Foldes, and P L Goldiner
December 2001, Brain research bulletin,
G T Somogyi, and E S Vizi, and I A Chaudhry, and H Nagashima, and D Duncalf, and F F Foldes, and P L Goldiner
November 1991, Japanese journal of pharmacology,
G T Somogyi, and E S Vizi, and I A Chaudhry, and H Nagashima, and D Duncalf, and F F Foldes, and P L Goldiner
June 2002, Neurochemistry international,
G T Somogyi, and E S Vizi, and I A Chaudhry, and H Nagashima, and D Duncalf, and F F Foldes, and P L Goldiner
December 1986, Naunyn-Schmiedeberg's archives of pharmacology,
G T Somogyi, and E S Vizi, and I A Chaudhry, and H Nagashima, and D Duncalf, and F F Foldes, and P L Goldiner
December 1994, Japanese journal of pharmacology,
G T Somogyi, and E S Vizi, and I A Chaudhry, and H Nagashima, and D Duncalf, and F F Foldes, and P L Goldiner
July 1987, Neuroscience,
G T Somogyi, and E S Vizi, and I A Chaudhry, and H Nagashima, and D Duncalf, and F F Foldes, and P L Goldiner
August 1994, Japanese journal of pharmacology,
G T Somogyi, and E S Vizi, and I A Chaudhry, and H Nagashima, and D Duncalf, and F F Foldes, and P L Goldiner
May 2000, Life sciences,
G T Somogyi, and E S Vizi, and I A Chaudhry, and H Nagashima, and D Duncalf, and F F Foldes, and P L Goldiner
May 1997, Respiration physiology,
G T Somogyi, and E S Vizi, and I A Chaudhry, and H Nagashima, and D Duncalf, and F F Foldes, and P L Goldiner
January 1982, Neurobehavioral toxicology and teratology,
Copied contents to your clipboard!